Current Edition About Subscribe The Jerusalem Center

Daily Alert Archive

Every Daily Alert Since 2002

Search

Search more than 90,000 news items by topic, author, or source.
Use " " to search for multiple words and phrases.

Trending Topics

February 9, 2018       Share:    

Source: https://www.timesofisrael.com/israel-innovation-makes-up-half-of-merck-healthcare-revenue-top-official-says/

Israeli Innovation Makes Up Half of Merck Healthcare Revenue

(Times of Israel) Shoshanna Solomon - "Roughly almost half of (our) healthcare revenue is based on innovation stemming from Israel," Kai Beckmann, CEO of Performance Materials at Germany's Merck pharmaceutical and chemicals firm, said in an interview on Tuesday. The Rebif drug marketed by Merck to help decrease the frequency of relapse symptoms of multiple sclerosis had sales of 1.7 billion euros in 2016, while the Erbitux drug for patients with cancer of the head and neck, also based on Israeli technology, had global sales of 1 billion euros. Beckmann was in Israel to inaugurate a new technology innovation laboratory at its subsidiary, Qlight Nanotech, in Jerusalem.

View the full edition of Daily Alert

Back to Archive

Subscribe to Daily Alert: